Jielun Lu
Overview
Explore the profile of Jielun Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu J, Chen S, Tan H, Huang Z, Li B, Liu L, et al.
J Cancer Res Clin Oncol
. 2021 Jul;
147(11):3157-3168.
PMID: 34232382
Purpose: The expression of eukaryotic translation initiation factor-2 subunit 3 (EIF2S3) in patients with non-small cell lung and colorectal cancer is lower than that in healthy individuals. However, the functions...
2.
Chen Y, Chen S, Lu J, Yuan D, He L, Qin P, et al.
Medicine (Baltimore)
. 2021 May;
100(18):e25807.
PMID: 33950983
Background: Runt-related transcription factor 1 (RUNX1) is one of the most frequently mutated genes in most of hematological malignancies, especially in acute myeloid leukemia. In the present study, we aimed...
3.
Chen S, Chen Y, Lu J, Yuan D, He L, Tan H, et al.
Biomed Res Int
. 2020 Dec;
2020:9321630.
PMID: 33299888
Background: DNA methyltransferase 3 alpha (DNMT3A) mutation was one of the most frequent genetic alterations in acute myeloid leukemia (AML), which was associated with poor prognosis and appeared to be...
4.
Chen S, Chen Y, Zhu Z, Tan H, Lu J, Qin P, et al.
Int J Med Sci
. 2020 Jun;
17(9):1269-1280.
PMID: 32547322
: Associated with poor prognosis, FMS-like tyrosine kinase 3 (FLT3) mutation appeared frequently in acute myeloid leukemia (AML). Herein, we aimed to identify the key genes and miRNAs involved in...
5.
Lu J, Tan H, Li B, Chen S, Xu L, Zou Y
Oncol Lett
. 2020 Jan;
19(1):972-984.
PMID: 31897210
The purpose of the present study was to evaluate the newest status of patients diagnosed Burkitt lymphoma (BL), an aggressive lymphoma subset with a high cure rate. Furthermore, the study...